Home LiteratureArticle Details
PMID: 1963286 Published · ppublish English Journal Article

Broad-host-range gyrase A gene probe.

Antimicrobial agents and chemotherapy ·Vol. 34 ·No. 10 ·1990-10-00 ·Pages 1889-94

Robillard NJ

Abstract

The Escherichia coli gyrase A gene was cloned in the broad-host-range cosmid vector pLA2917. The resulting plasmid, pNJR3-2, conferred quinolone susceptibility on a gyrA mutant of E. coli. To analyze the expression of this E. coli gene in Pseudomonas aeruginosa, pNJR3-2 or pLA2917 was mobilized via conjugation into P. aeruginosa PAO2 and several well-characterized quinolone-resistant mutants of this strain. The vector pLA2917 did not significantly affect the quinolone susceptibilities of any of the P. aeruginosa strains. However, pNJR3-2 conferred wild-type quinolone susceptibility on P. aeruginosa cfxA (gyrA) mutants and intermediate quinolone susceptibility on cfxA-cfxB double mutants of P. aeruginosa. The quinolone susceptibility of P. aeruginosa PAO2 gyrA+ was unaffected by pNJR3-2. Also, pNJR3-2 had no significant effect on P. aeruginosa cfxB (permeability) mutants. These results demonstrate that the DNA gyrase A gene from E. coli is expressed in P. aeruginosa and confers dominant susceptibility on gyrA mutants. Thus, pNJR3-2 can be used to detect the quinolone resistance mutations that occur in the gyrase A gene of this organism. pNJR3-2 also appears to discriminate between mutations in gyrA and mutations which alter permeability. This gyrase A probe was used successfully in the analysis of quinolone resistance in clinical isolates of P. aeruginosa.

MeSH Terms
Anti-Bacterial Agents/pharmacology DNA Topoisomerases, Type II/genetics,isolation & purification Escherichia coli/drug effects,genetics Gene Expression Regulation, Bacterial Gene Expression Regulation, Enzymologic Genes, Bacterial Genetic Vectors Genotype Microbial Sensitivity Tests Phenotype Plasmids Pseudomonas aeruginosa/drug effects,genetics
Chemicals
Anti-Bacterial Agents DNA Topoisomerases, Type II
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Robillard N J
Pharmaceutical Division, Miles Inc., West Haven, Connecticut 06516.
References (30)
30 references, click to expand
  1. Construction of broad-host-range cosmid cloning vectors: identification of genes necessary for growth of Methylobacterium organophilum on methanol.
    J Bacteriol. 1985 Mar;161(3):955-62 PMID: 2982796
  2. Correlation between lipopolysaccharide structure and permeability resistance in beta-lactam-resistant Pseudomonas aeruginosa.
    Antimicrob Agents Chemother. 1984 Aug;26(2):181-6 PMID: 6435513
  3. Analysis of the vegetative replication origin of broad-host-range plasmid RK2 by transposon mutagenesis.
    Plasmid. 1986 Mar;15(2):132-46 PMID: 3010353
  4. Purification and properties of DNA gyrase from a fluoroquinolone-resistant strain of Escherichia coli.
    Antimicrob Agents Chemother. 1986 Nov;30(5):777-80 PMID: 3026239
  5. Some properties of subunits of DNA gyrase from Pseudomonas aeruginosa PAO1 and its nalidixic acid-resistant mutant.
    J Bacteriol. 1987 May;169(5):2322-5 PMID: 3032915
  6. Mechanisms of action of and resistance to ciprofloxacin.
    Am J Med. 1987 Apr 27;82(4A):12-20 PMID: 3034057
  7. Mutations producing resistance to norfloxacin in Pseudomonas aeruginosa.
    Antimicrob Agents Chemother. 1987 Apr;31(4):582-6 PMID: 3111356
  8. Cloning and sequencing of the Escherichia coli gyrA gene coding for the A subunit of DNA gyrase.
    J Mol Biol. 1987 Oct 20;197(4):729-36 PMID: 2828631
  9. Quinolone-resistant mutations of the gyrA gene of Escherichia coli.
    Mol Gen Genet. 1988 Jan;211(1):1-7 PMID: 2830458
  10. Development of resistance in Pseudomonas aeruginosa to imipenem, norfloxacin, and ciprofloxacin during therapy: proof provided by typing with a DNA probe.
    J Infect Dis. 1988 Apr;157(4):743-8 PMID: 3126247
  11. Mapping and characterization of two mutations to antibiotic supersusceptibility in Pseudomonas aeruginosa.
    J Gen Microbiol. 1987 Oct;133(10):2905-14 PMID: 3130461
  12. Genetic and physiological characterization of ciprofloxacin resistance in Pseudomonas aeruginosa PAO.
    Antimicrob Agents Chemother. 1988 Apr;32(4):535-9 PMID: 2837141
  13. Outer membrane alterations in multiresistant mutants of Pseudomonas aeruginosa selected by ciprofloxacin.
    Antimicrob Agents Chemother. 1989 Jan;33(1):124-7 PMID: 2496655
  14. gyrA and gyrB mutations in quinolone-resistant strains of Escherichia coli.
    Antimicrob Agents Chemother. 1989 Feb;33(2):254-5 PMID: 2655532
  15. Central catheter infection: single-versus triple-lumen catheters.
    Am J Med. 1989 Jul;87(1):2-3 PMID: 2500854
  16. Characterization of mechanisms of quinolone resistance in Pseudomonas aeruginosa strains isolated in vitro and in vivo during experimental endocarditis.
    Antimicrob Agents Chemother. 1989 May;33(5):624-34 PMID: 2502066
  17. Cloning and characterization of a DNA gyrase A gene from Escherichia coli that confers clinical resistance to 4-quinolones.
    Antimicrob Agents Chemother. 1989 Jun;33(6):886-94 PMID: 2548439
  18. Factors influencing the accumulation of ciprofloxacin in Pseudomonas aeruginosa.
    Antimicrob Agents Chemother. 1989 Nov;33(11):1921-6 PMID: 2514623
  19. Analysis of acquired ciprofloxacin resistance in a clinical strain of Pseudomonas aeruginosa.
    Antimicrob Agents Chemother. 1990 Feb;34(2):281-6 PMID: 2158277
  20. Proportion of DNA gyrase mutants among quinolone-resistant strains of Pseudomonas aeruginosa.
    Antimicrob Agents Chemother. 1990 Jun;34(6):1273-5 PMID: 2168149
  21. Resistance of Pseudomonas aeruginosa to new beta-lactamase-resistant beta-lactams.
    Antimicrob Agents Chemother. 1984 Oct;26(4):485-8 PMID: 6440472
  22. Escherichia coli K-12 mutants resistant to nalidixic acid: genetic mapping and dominance studies.
    J Bacteriol. 1969 Jul;99(1):238-41 PMID: 4895844
  23. Comparisons of F factors and R factors: existence of independent regulation groups in F factors.
    J Bacteriol. 1970 Jul;103(1):81-8 PMID: 4912532
  24. Mechanism of action of nalidixic acid: purification of Escherichia coli nalA gene product and its relationship to DNA gyrase and a novel nicking-closing enzyme.
    Proc Natl Acad Sci U S A. 1977 Nov;74(11):4767-71 PMID: 200930
  25. Nalidixic acid resistance: a second genetic character involved in DNA gyrase activity.
    Proc Natl Acad Sci U S A. 1977 Nov;74(11):4772-6 PMID: 337300
  26. DNA gyrase and the supercoiling of DNA.
    Science. 1980 Feb 29;207(4434):953-60 PMID: 6243420
  27. The intrinsic ATPase of DNA gyrase.
    J Biol Chem. 1980 Jul 10;255(13):6299-306 PMID: 6248518
  28. DNA topoisomerases.
    Annu Rev Biochem. 1981;50:879-910 PMID: 6267993
  29. DNA gyrase: affinity chromatography on novobiocin-Sepharose and catalytic properties.
    Nucleic Acids Res. 1981 Aug 11;9(15):3589-603 PMID: 6269086
  30. Resistance of Pseudomonas aeruginosa PAO to nalidixic acid and low levels of beta-lactam antibiotics: mapping of chromosomal genes.
    Antimicrob Agents Chemother. 1982 Aug;22(2):242-9 PMID: 6821455
Article Info
Journal
Antimicrobial agents and chemotherapy
Abbr.
Antimicrob Agents Chemother
ISSN
0066-4804
Published
1990-10-00
Pages
1889-94
Language
English
Region
United States
NLM ID
0315061
PMCID
PMC171960
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com